Answers are grounded in this paper and cite their sources.
PROLOGUE: Schizophrenia, a chronic psychotic condition, has been highly misunderstood and stigmatized, both among medical professionals and in the general public, because of the disruptive and sometimes violent behavior associated with it. Up until recently the drugs that were available to treat schizophrenia had such severe side effects that it was difficult to maintain compliance with a treatment regimen. Recent advances in drug and other treatments, though, have improved patients' experiences with their therapies and have made it at least theoretically possible for them to return to more normal lives. However, many patients still have not benefited from these advances, for a variety of reasons. In 1992 the Agency for Health Care Policy and Research and the National Institute of Mental Health initiated the schizophrenia Patient Outcomes Research Team (PORT) project, whose treatment recommendations were issued in January 1998. These recommendations “provide a basis for moving toward ‘evidence-based’ practice for schizophrenia and identify both the strengths and limitations in our current knowledge base,” according to Schizophrenia Bulletin . The author of this paper, Anthony Lehman, directed the schizophrenia PORT project and presents here a summary of its findings and their implications for treating chronic mental illness. Lehman is a professor of psychiatry at the University of Maryland School of Medicine, where he directs the Center for Mental Health Services Research. He holds a medical degree from the University of Rochester (New York) and a master of science degree in public health from the University of California, Los Angeles. ABSTRACT: Scientific evidence supporting the efficacy of a range of treatments for persons with schizophrenia set the stage for the recent development of evidence-based quality-of-care indicators for this disorder. On the heels of these quality indicators, research has found that treatment services for many persons with schizophrenia are inadequate. Because most of these patients receive their care under public auspices (Medicaid, Medicare, and Veterans Affairs), public health policy can exert considerable influence to address these quality-of-care problems. Publicly funded managed care could promote evidence-based care. It also could coordinate specialty and primary care to improve early detection and general medical care for persons with schizophrenia.
No takes yet. Share an insight, caveat, or question.
Anthony F. Lehman (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: